Photosensitizing and radiosensitizing effects of mitoxantrone: Combined chemo-, photo-, and radiotherapy of DFW human melanoma cells

Lasers in Medical Science

Volumn 28, Issue 6, 2013, Pages 1533-1539

  Sazgarnia, Ameneh ^a   Montazerabadi, Ali Reza ^b   Bahreyni Toosi, Mohammad Hossein ^a   Ahmadi, Amirhossein ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Melanoma; Mitoxantrone; Photosensitive; Radiosensitive

Indexed keywords

MITOXANTRONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIOSENSITIZATION; X IRRADIATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; HUMANS; MELANOMA; MITOXANTRONE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RADIATION-SENSITIZING AGENTS;

EID: 84888198618     PISSN: 02688921     EISSN: 1435604X     Source Type: Journal    
DOI: 10.1007/s10103-013-1275-8     Document Type: Article

References (34)

1. Garbe C, Blum A (2001) Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 14:280-290
2. Oppermann M, Geilen CC, Fecker LF, Gillissen B, Daniel PT, Eberle J (2005) Caspase independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk/Bik. Oncogene 24:7369-7380
3. Helmbach H, Rossmann E, Kern MA, Schadendorf D (2001) Drug-resistance in human melanoma. Int J Cancer 93:617-622
4. Garbe C, Peris K, Hauschild A et al (2010) Eggermont, diagnosis and treatment of melanoma: European consensus-based interdisciplinary guidelines. Eur J Cancer 46:270-283
5. Berk LB (2008) Radiation therapy as primary and adjuvant treatments for local and regional melanoma. Canc Contr 15:233-237
6. Baas P, Murrer L, Zoetmulder FAN et al (1997) Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br J Cancer 76:819-826
7. Sabel MS, Sondak VK (2003) Pros and cons of adjuvant interferon in the treatment of melanoma. Oncologist 8:451-458
8. Kiesslich T, Krammer B, Plaetzer K (2006) Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. Curr Med Chem 13:2189-2204
9. Milanesio ME, Morán FS, Yslas EI, Alvarez MG, Rivarola V, Durantini EN (2001) Synthesis and biological evaluation of methoxyphenyl porphyrin derivatives as potential photodynamic agents. Bioorg Med Chem 9:1943-1949
10. Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3:380-387
11. Dougherty TJ (1987) Photosensitizers: therapy and detection of malignant tumors. Photochem Photobiol 45:879-889
12. Kukielczak B, Cieszka KA, Matuszak ZT, Subczynski WK (1995) Experimental photodynamic therapy of Bomirski hamster melanoma using merocyanine 540 and visible light. Curr Top Biophys 19:6-70
13. Chedekel MR (1995) Photophysics and photochemistry of melanin. In: Zeise L, Chedekel MR, Fitzpatrick TB (eds) Melanin: its role in human photoprotection. Valdenmar Publ Co, Overland Park, pp 11-21
14. Dun FE (1984) Biologic and biochemical effects of mitoxantrone. Semin Oncol 11:3-10
15. Harker WG, Slade DL, Dalton WS, Meltzer PS, Trent JM (1989) Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression. Cancer Res 49:4542-4549
16. Lenk H, Muller U, Tanneberger S (1987) Mitoxantrone: mechanism of action, antitumor activity, pharmacokinetics. Efficacy in the treatment of solid tumors and lymphomas, and toxicity. Anticancer Res 7:1257-1264
17. Montazerabadi AR, Sazgarnia A, Bahreyni-Toosi MH, Ahmadi A, Shakeri Zadeh A, Aledavood A (2012) Mitoxantrone as a prospective photosensitizer for photodynamic therapy of breast cancer. Photodiagnosis Photodyn Ther 9:46-51
18. Jassem J, Begg AC, Stewart F, Bartelink H (1995) Combined chemotherapy and radiotherapy. In: Peckham M, Pinedo HM, Veronesi U (eds) Oxford textbook of oncology. Oxford University Press, Oxford, pp 811-823
19. Toledano A, Azria D, Garaud P et al (2007) Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial. J Clin Oncol 25:405-410
20. Valagussa P, Zambetti M, Biasi S, Moliterni A, Zucali R, Bonadonna G (1994) Cardiac effects following adjuvant chemotherapy and beast irradiation in operable breast cancer. Ann Oncol 5:209-216
21. Colasanti A, Kisslinger M, Quarto M, Riccio P (2004) Combined effects of radiotherapy and photodynamic therapy on an in vitro human prostate model. Acta Biochim Pol 51:1039-1046
22. Prinsze C, Penning LC, Dubbelman TMAR, Van Steveninck J (1992) Interaction of photodynamic treatment and either hyperthermia or ionizing radiation and of ionizing radiation and hyperthermia with respect to cell killing of L929 fibroblasts, Chinese hamster ovary cells, and T24 human bladder cells. Cancer Res 52:117-120
23. Montazerabadi AR, Sazgarnia A, Bahreyni-Toosi MH, Ahmadi A, Aledavood A (2012) The effects of combined treatment with ionizing radiation and Indocyanine green-mediated photodynamic therapy on breast cancer cells. J Photochem Photobiol B 2 109:42-49
24. Hammer-Wilson MJ, Sun CH, Ghahramanlou M, Berns MW (1998) In vitro and in vivo comparison of argon-pumped and diode lasers for photodynamic therapy using second-generation photosensitizers. Lasers Surg Med 23:274-280
25. Sternberg ED, Dolphin D (1993) Second-generation photodynamic agents: a review. J Clin Laser Med Surg 11:233-241
26. Kanofsky JR, Sima PD (2000) Preferential cytotoxicity for multidrug-resistant K 562 cells using the combination of a photosensitizer and a cyanine dye. J Photochem Photobiol B 54:136-144
27. Reszka K, Kolodziejczyk P, Tsoungas PG, Lown JW (1988) Photosensitization by antitumor agents. 6. Production of superoxide radical and hydrogen peroxide during illumination of diaminoanthracenediones in the presence of NADH in aqueous solutions: an EPR study. Photochem Photobiol 47:297-304
28. Reszka K, Lown JW (1989) Photosensitization of anticancer agents. 8. One-electron reduction of mitoxantrone: an EPR and spectrophotometric study. Photochem Photobiol 50:625-633
29. Andreoni A, Colasanti A, Roberti G (1992) Excited singlet state properties of anthracenedione photosensitizers. J Photochem Photobiol B 14:319-328
30. Myers CE, Mimnaugh E, Yeh G, Sinha BK (1988) Biochemical mechanisms of tumor cell kill by the anthracyclines. In: Lown JW (ed) Anthracycline and anthracenedione-based anticancer agents. Elsevier, New York, pp 131-162
31. Paiva MB, Saxton RE, Letts G et al (1996) Laser photochemotherapy with anthracyclines on cultured human squamous carcinoma cells. Laryngoscope 106:257-262
32. Lanks KW, Gao JP, Sharma T (1994) Photodynamic enhancement of doxorubicin cytotoxicity. Cancer Chemother Pharmacol 35:17-20
33. Ramakrishnan N, Clay ME, Friedman LR, Antunez AR, Oleinick NL (1990) Post-treatment interactions of photodynamic and radiation induced cytotoxic lesions. Photochem Photobiol 52(3):555-559
34. Mateos S, Hajji N, Pastor N, Cortés F (2006) Modulation of radiation response by inhibiting topoisomerase II catalytic activity. Mutat Res 599(1-2):105-115